Double maintains 2 strategies that include BHVN - Biohaven Ltd.
Yahoo
Volatile biotech stock Biohaven (NYSE: BHVN) is prone to sharp movements both up and down. After market close on Wednesday, Biohaven divulged that the U.S. Food and Drug Administration's (FDA) Division of Neurology 1 is extending the due date for its decision on a very promising pipeline drug developed by the company. Specifically, the FDA unit is extending the Prescription Drug User Fee Act (PDUFA) date for Biohaven's troriluzole, a treatment that targets brain disorder spinocerebellar ataxia (SCA), by three months.
Yahoo
Biohaven shares plunged Thursday after the Food and Drug Administration unexpectedly delayed the review date for its rare-disease drug.
Yahoo
Biohaven Ltd. (NYSE:BHVN) shares plunged on Thursday after the Food and Drug Administration (FDA) unexpectedly delayed the review date for its rare-disease drug troriluzole. The Division of Neurology 1 within FDA’s Office of Neuroscience informed Biohaven that they are extending the PDUFA date for the troriluzole new drug application (NDA) for spinocerebellar ataxia (SCA) by three months to provide time for a full review of Biohaven’s recent submissions related to information requests from the F
Yahoo
Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), today announced that the Division of Neurology 1 within FDA's Office of Neuroscience informed the Company that they are extending the PDUFA date for the troriluzole new drug application (NDA) for the treatment of spinocerebellar ataxia (SCA) by three months to provide time for a full review of Biohaven's recent submissions related to information requests from the FDA. The Division also informed Biohaven that it is currently planning to hold a
Yahoo
Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases, today reported financial results for the first quarter ended March 31, 2025, and provided a review of recent accomplishments and anticipated upcoming developments.
Finnhub
Biohaven Ltd: * BIOHAVEN Q1 NET INCOME USD -221.677 MILLION * BIOHAVEN Q1 PROFIT FROM OPERATIONS USD -221.561 MILLION * BIOHAVEN Q1 BASIC EPS USD -2.17 ...
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
HYMB | 0.06% | $2.53B | 0.35% |
WEAT | 0.07% | $115.83M | 0.28% |
GTO | -0.10% | $1.89B | 0.35% |
USTB | 0.14% | $1.19B | 0.35% |
GSST | -0.23% | $857.21M | 0.16% |
NYF | -0.24% | $875.13M | 0.25% |
IUSB | -0.26% | $32.72B | 0.06% |
ITM | 0.33% | $1.97B | 0.18% |
PZA | 0.38% | $2.89B | 0.28% |
BSMR | 0.48% | $245.57M | 0.18% |
JCPB | -0.58% | $6.25B | 0.38% |
CGSD | 0.65% | $1.19B | 0.25% |
IBDW | 0.69% | $1.47B | 0.1% |
YEAR | 0.73% | $1.40B | 0.25% |
UNG | -0.73% | $371.83M | 1.06% |
TBIL | 0.79% | $5.76B | 0.15% |
EUSB | -0.79% | $683.69M | 0.12% |
SUSB | 0.82% | $967.17M | 0.12% |
AVIG | -0.83% | $1.06B | 0.15% |
BLV | 0.83% | $6.01B | 0.03% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DOGZ | -0.09% | $231.95M | +120.05% | 0.00% |
CNK | 0.24% | $3.67B | +78.94% | 0.25% |
CPB | -0.30% | $10.42B | -25.16% | 4.36% |
CI | -0.33% | $82.51B | -8.96% | 1.84% |
IMNN | 0.48% | $8.21M | -59.89% | 0.00% |
HTO | -0.50% | $1.76B | -13.86% | 3.19% |
PULM | -0.52% | $23.82M | +239.64% | 0.00% |
CMS | -0.56% | $21.21B | +12.27% | 2.97% |
AMT | -0.61% | $99.10B | +8.59% | 3.09% |
CCEC | -0.65% | $1.02B | +3.91% | 2.71% |
PPC | -0.71% | $11.21B | +41.54% | 0.00% |
MNOV | -0.74% | $68.17M | -2.80% | 0.00% |
HEES | 0.74% | $3.52B | +99.54% | 1.15% |
PEP | 0.86% | $180.30B | -28.19% | 4.14% |
TU | -0.88% | $23.77B | -4.62% | 7.19% |
BTCT | 0.93% | $25.35M | +93.08% | 0.00% |
WBA | 0.95% | $9.67B | -39.04% | 6.69% |
JNJ | 0.97% | $360.54B | -3.03% | 3.32% |
MOH | -1.01% | $17.02B | -8.99% | 0.00% |
VRCA | -1.03% | $59.36M | -92.99% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LFUS | 49.31% | $5.35B | -13.23% | 1.28% |
BEAM | 49.01% | $1.73B | -27.49% | 0.00% |
URI | 48.76% | $46.37B | +4.72% | 0.96% |
SYRE | 48.60% | $877.54M | -61.53% | 0.00% |
IVZ | 48.30% | $6.86B | -4.79% | 5.38% |
KYMR | 47.49% | $1.95B | -15.67% | 0.00% |
LAZ | 47.41% | $4.35B | +13.57% | 4.36% |
EVR | 47.27% | $9.17B | +19.07% | 1.35% |
CVLG | 47.25% | $620.88M | -0.36% | 1.71% |
RVMD | 47.17% | $7.35B | +1.15% | 0.00% |
OCUL | 47.09% | $1.14B | +14.35% | 0.00% |
FLS | 47.07% | $6.68B | +2.49% | 1.64% |
TPG | 46.91% | $6.00B | +18.02% | 3.34% |
ARCB | 46.78% | $1.55B | -41.14% | 0.71% |
EWBC | 46.63% | $13.11B | +22.95% | 2.43% |
XENE | 46.51% | $2.27B | -26.70% | 0.00% |
ELVN | 46.48% | $874.36M | -25.16% | 0.00% |
GNRC | 46.16% | $7.53B | -10.87% | 0.00% |
HPE | 46.07% | $23.15B | -1.51% | 2.95% |
ITT | 46.05% | $11.82B | +8.44% | 0.87% |
Current Value
$15.951 Year Return
Current Value
$15.951 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 59.59% | $4.85B | 0.35% |
KJUL | 54.19% | $113.35M | 0.79% |
IWO | 53.85% | $11.36B | 0.24% |
VXF | 53.23% | $21.56B | 0.05% |
SCHA | 53.16% | $16.91B | 0.04% |
TMSL | 53.09% | $748.48M | 0.55% |
GNOM | 53.00% | $40.65M | 0.5% |
VTWO | 52.95% | $12.07B | 0.07% |
XTN | 52.83% | $200.95M | 0.35% |
NUSC | 52.73% | $1.14B | 0.31% |
VBK | 52.71% | $18.33B | 0.07% |
ESML | 52.71% | $1.81B | 0.17% |
IWM | 52.70% | $63.95B | 0.19% |
VB | 52.59% | $62.13B | 0.05% |
KJAN | 52.54% | $305.13M | 0.79% |
CPRJ | 52.29% | $48.43M | 0.69% |
SMMD | 52.18% | $1.46B | 0.15% |
IWC | 52.12% | $766.88M | 0.6% |
RYLD | 52.01% | $1.29B | 0.6% |
IJH | 51.81% | $93.03B | 0.05% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -24.40% | $22.95B | +20.67% | 1.12% |
ED | -14.41% | $36.75B | +5.26% | 3.28% |
CME | -13.53% | $98.74B | +28.80% | 3.84% |
AWK | -13.26% | $27.37B | +4.54% | 2.22% |
LITB | -12.07% | $21.28M | -72.45% | 0.00% |
FMTO | -9.97% | $45.74M | -99.96% | 0.00% |
COR | -9.69% | $55.43B | +28.90% | 0.56% |
CL | -9.53% | $72.64B | -5.18% | 2.25% |
K | -8.65% | $28.49B | +32.17% | 2.77% |
MKTX | -8.44% | $8.01B | -1.42% | 1.39% |
EXC | -7.47% | $43.84B | +12.45% | 3.59% |
DUK | -6.94% | $90.12B | +12.74% | 3.61% |
AEP | -6.66% | $54.28B | +9.80% | 3.61% |
VZ | -6.49% | $183.32B | +8.02% | 6.21% |
MCK | -6.15% | $88.42B | +27.17% | 0.39% |
MO | -5.98% | $97.80B | +26.35% | 6.94% |
KMB | -5.43% | $45.57B | +1.99% | 3.58% |
MSEX | -4.03% | $1.02B | -1.01% | 2.34% |
FL | -3.98% | $2.27B | +8.64% | 0.00% |
HSY | -3.79% | $33.16B | -21.37% | 3.44% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -44.72% | $140.49M | 0.59% |
BTAL | -42.17% | $361.41M | 1.43% |
VIXY | -38.64% | $109.64M | 0.85% |
FTSD | -30.65% | $212.46M | 0.25% |
IVOL | -25.09% | $353.94M | 1.02% |
SCHO | -20.31% | $10.87B | 0.03% |
SPTS | -18.45% | $5.76B | 0.03% |
VGSH | -17.65% | $22.38B | 0.03% |
XONE | -16.95% | $603.24M | 0.03% |
UTWO | -16.04% | $387.71M | 0.15% |
FXY | -15.55% | $838.61M | 0.4% |
LDUR | -14.81% | $849.09M | 0.5% |
IEI | -14.61% | $16.09B | 0.15% |
IBTH | -14.52% | $1.53B | 0.07% |
AGZ | -14.28% | $607.46M | 0.2% |
IBTI | -14.13% | $995.39M | 0.07% |
IBTK | -13.89% | $431.59M | 0.07% |
VGIT | -13.56% | $31.33B | 0.04% |
ULST | -13.39% | $637.77M | 0.2% |
IBTJ | -13.23% | $658.04M | 0.07% |